Expression clone of lacZ.
Alternative name | stock no 240 |
---|---|
Clone info. | Expression clone of lacZ under the control of CAG promoter. |
Vector backbone | pCAGGS (Plasmid) |
Size of vector backbone | 4.8 kb |
Selectable markers | Amp^r |
Growth conditions | 37C, LB+Amp |
Gene/insert name | E. coli lacZ genomic DNA |
Depositor|Developer | Niwa, Hitoshi | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Additional terms and conditions: Regarding resources containing CAG promoter: In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation for the CAG promoter (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991) and an acknowledgment to Dr. Jun-ich Miyazaki of the Osaka University are requested. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する。 MTAに書く付加的使用条件: CAGプロモータを含むリソースについて: 利用者は、研究成果の公表にあたってCAGプロモータの文献 (Niwa, H., Yamamura, K., Miyazaki, J., Gene 108 : 193-200, 1991)を引用し、大阪大学 宮崎純一博士への謝辞の表明を必要とする。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB09309 | pCAGGS lacZ | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pCAGGS lacZ was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB09309). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB09309_A9Fcp1-1.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CAG_R1 () Sequence file: RDB09309_A9Fca.seq ![]() |
---|
>09309_09309_A9Fc_2_CAG_R1_C05_08_ABI24.ab1 1 TGAAACGCGG CCGCACCCCT CTAGCGGGCG CGGGGCGAAG CGGTGCGGCG CCGGCAGGAA 61 GGAAATGGGC GGGGAGGGCC TTCGTGCGTC GCCGCGCCGC CGTCCCCTTC TCCCTCTCCA 121 GCCTCGGGGC TGTCCGCGGG GGGACGGCTG CCTTCGGGGG GGACGGGGCA GGGCGGGGTT 181 CGGCTTCTGG CGTGTGACCG GCGGCTCTAG AGCCTCTGCT AACCATGTTC ATGCCTTCTT 241 CTTTTTCCTA CAGCTCCTGG GCAACGTGCT GGTTATTGTG CTGTCTCATC ATTTTGGCAA 301 AGAATTCAAG CTTGGGATCT CTATAATCTC GCGCAACCTA TTTTCCCCTC GAACACTTTT 361 TAAGCCGTAG ATAAACAGGC TGGGACACTT CACATGAGCG AAAAATACAT CGTCACCTGG 421 GACATGTTGC AGATCCATGC ACGTAAACTC GCAAGCCGAC TGATGCCTTC TGAACAATGG 481 AAAGGCATTA TTGCCGTAAG CCGTGGCGGT CTGGTACCGG TGGGTGAAGA CCAGAAACAG 541 CACCTCGAAC TGAGCCGCGA TATTGCCCAG CGTTTCAACG CGCTGTATGG CGAGATCGAT 601 CCCGTCGTTT TACAACGTCG TGACTGGGAA AACCCTGGCG TTACCCAACT TAATCGCCTT 661 GCAGCACATC CCCCTTTCGC CAGCTGGCGT AATAGCGAAG AGGCCCGCAC CGATCGCCCT 721 TCCCAACAGT TGCGCAGCCT GAATGGCGAA TGGCGCTTTG CCTGGTTTCC GGCACCAGAA 781 GCGGTGCCGG AAAGCTGGCT GGAGTGCGAT CTTCCTGAGG CCGATACTGT CGTCGTCCCC 841 TCAAACTGGC AGATGCACGG TTACGATGCG CCCATCTACA CCAACGTGAC CTATCCCATT 901 ACGGTCAATC CGCCGTTTGT TCCCACGGAG AATCCGACGG GTTGTTACTC GCTCACATTT 961 AATGTTGATG AAAGCTGGCT ACAGAAGGCC AGACGCGAAT TATTTTTTGA TGGCGTTAAC 1021 TCGGCGTTTC ATCTGTGGTG CAACGGGCGC CTGGGTCGGT TACGGCCAGG ACAGGTCGTT 1081 TTGTCGTCCT GGAATTGGAA CATGAAGCGC CAGTTTTTAC GCCCGCCCCC GGGAAGAAAA 1141 AAAA // |
Primer: pCAGGS_R1 () Sequence file: RDB09309_A9Fcb.seq ![]() |
>09309_09309_A9Fc_2pCAGGS_R1_D05_11_ABI24.ab1 1 AAAAATTCCA ACACACTATT GCAATGAAAA TAAATTTCCT TTATTAGCCA GAAGTCAGAT 61 GCTCAAGGGG CTTCATGATG TCCCCATAAT TTTTGGCAGA GGGAAAAAGA TCTCAGTGGT 121 ATTTGTGAGC CAGGGCATTG GCCACACCAG CCACCACCTT CTGATAGGCA GCCTGCACCT 181 GAGGAGTGAA TTCCTCGACG GATCCCCCCT GCCCGGTTAT TATTATTTTT GACACCAGAC 241 CAACTGGTAA TGGTAGCGAC CGGCGCTCAG CTGGAATTCC GCCGATACTG ACGGGCTCCA 301 GGAGTCGTCG CCACCAATCC CCATATGGAA ACCGTCGATA TTCAGCCATG TGCCTTCTTC 361 CGCGTGCAGC AGATGGCGAT GGCTGGTTTC CATCAGTTGC TGTTGACTGT AGCGGCTGAT 421 GTTGAACTGG AAGTCGCCGC GCCACTGGTG TGGGCCATAA TTCAATTCGC GCGTCCCGCA 481 GCGCAGACCG TTTTCGCTCG GGAAGACGTA CGGGGTATAC ATGTCTGACA ATGGCAGATC 541 CCAGCGGTCA AAACAGGCGG CAGTAAGGCG GTCGGGATAG TTTTCTTGCG GCCCTAATCC 601 GAGCCAGTTT ACCCGCTCTG CTACCTGCGC CAGCTGGCAG TTCAGGCCAA TCCGCGCCGG 661 ATGCGGTGTA TCGCTCGCCA CTTCAACATC AACGGTAATC GCCATTTGAC CACTACCATC 721 AATCCGGTAG GTTTTCCGGC TGATAAATAA GGTTTTCCCC TGATGCTGCC ACGCGTGAGC 781 GGTCGTAATC AGCACCGCAT CAGCAAGTGT ATCTGCCGTG CACTGCAACA ACGCTGCTTC 841 GGCCTGGTAA TGGCCCGCCG CCTTCCAGCG TTCGACCCAG GCGTTAGGGT CAATGCGGGT 901 CGCTTCACTT ACGCCAATGT CGTTATCCAG CGGTGCACGG GTGAACTGAT CGCGCAGCGG 961 CGTCAGCAGT TGTTTTTTTA TCGCCCAATC CACATCTGTG AAAGAAAGCC CTGACTGGGC 1021 GGTTAAATTT GCCCAACGCT TATTACCCAG CTCGATGCAA AAATCCCATT TCGCTTGTTG 1081 TTCAGATGCG GGATTGGCCA TGGACGCGCG GGGCAGCGTT CACACTGAGG ATTTTTCCCG 1141 CCAAGAACGG TCA // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content